Mouse LSECs were isolated by previously described two-step collagenase perfusion technique with modifications15 (link). In brief, the liver was perfused with Liver Perfusion Medium (Invitrogen), and dissociated by Liver Digest Medium (Invitrogen). The NPCs were fractionated with Percoll® (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA) gradient centrifugation with 75% stock Percoll solution and 35% stock Percoll solution. LSEC faction was isolated by mouse LSEC binding magnetic beads (Miltenyi, Auburn, CA, USA) and Dynabeads® Magnetic Beads conjugated with anti-mouse CD31 antibody (MEC13.3, BD Biosciences). Expression of Id1, CXCR7, HGF, and Wnt2 mRNA were determined. Primary human LSECs were procured from ScienCell Research Laboratories (Catalog #5000, Carlsbad, CA, USA). Expression of factor VIII was validated by immunostaining. Akt-LSECs were derived from isolated LSECs that were transfected with the pCCL. PGK lentiviral vector with mouse constitutively active Akt1 (myristoylated Akt: myrAkt)63 (link). After starving in serum-free medium, 500,000 LSECs were seeded and stimulated with 10 ng/ml SDF-1. LSECs were also treated with 30 μM Wortmannin (Sigma-Aldrich).